According to OpGen 's latest financial reports the company's current EPS (TTM) is -$12.05. In 2022 the company made an earnings per share (EPS) of -$15.31 an increase over its 2021 EPS that were of -$24.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$12.05 | -21.29% |
2022 | -$15.31 | -36.21% |
2021 | -$24.00 | -31.82% |
2020 | -$35.20 | -88.83% |
2019 | -$315.20 | -66.09% |
2018 | -$929.40 | -79.88% |
2017 | -$4,620 | -60.51% |
2016 | -$11,700 | -23.15% |
2015 | -$15,224 | 158.87% |
2014 | -$5,881 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | -$0.68 | -94.36% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -$0.94 | -92.20% | ๐บ๐ธ USA |